cepharanthine has been researched along with Osteosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaki, S; Asaumi, J; Himei, K; Hiraki, Y; Kanazawa, S; Katsui, K; Komatsu, M; Kuroda, M; Takemoto, M; Wang, Y | 1 |
| Hoshi, N; Kobayashi, A; Okada, K; Sakusabe, N; Sato, K | 1 |
2 other study(ies) available for cepharanthine and Osteosarcoma
| Article | Year |
|---|---|
Cepharanthin enhances adriamycin sensitivity by synergistically accelerating apoptosis for adriamycin-resistant osteosarcoma cell lines, SaOS2-AR and SaOS2 F-AR.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Biological Transport; Bone Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Osteosarcoma | 2004 |
Prevention of lung metastasis by intra-tumoral injection of Cepharanthin and staphylococcal enterotoxin B in transplantable rat osteosarcoma.
Topics: Acid Phosphatase; Alkaloids; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Enterotoxins; In Situ Nick-End Labeling; Isoenzymes; Lung Neoplasms; Male; Neoplasm Transplantation; Organ Size; Osteosarcoma; Rats; Rats, Inbred F344; Tartrate-Resistant Acid Phosphatase | 1999 |